Focal macular electroretinograms after photodynamic therapy combined with intravitreal bevacizumab

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 249, Issue 2, 2011, Pages 273-280

  Ishikawa, Kohei ^a   Nishihara, Hiroaki ^a   Ozawa, Shinsuke ^a   Piao, Chang Hua ^a   Ito, Yasuki ^a   Kondo, Mineo ^a   Terasaki, Hiroko ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Age related macular degeneration; Bevacizumab; Electroretinogram; Indocyanine green angiography; Photodynamic therapy

Indexed keywords

BEVACIZUMAB; VERTEPORFIN;

A WAVE; AGED; ARTICLE; B WAVE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DIODE LASER; DRUG TOLERABILITY; ELECTRORETINOGRAM; ENDOPHTHALMITIS; FEMALE; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; INFLAMMATION; INTRAOCULAR HYPERTENSION; LUMINANCE; MALE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY; SUBRETINAL NEOVASCULARIZATION; UVEITIS; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROID; CHOROIDAL NEOVASCULARIZATION; COLORING AGENTS; COMBINED MODALITY THERAPY; ELECTRORETINOGRAPHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; PHOTOCHEMOTHERAPY; REGIONAL BLOOD FLOW; RETINA; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79952444340     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-010-1548-x     Document Type: Article

References (38)

1. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group 1999 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report 1 Arch Ophthalmol 117 1329 1345
2. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group 2001 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of two randomized clinical trials-TAP report 2 Arch Ophthalmol 119 198 207
3. Verteporfin in Photodynamic Therapy Study Group 2001 Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial. VIP report 1 Ophthalmology 108 841 852 10.1016/S0161-6420(01)00544-9 (Pubitemid 32374237)
4. Verteporfin in Photodynamic Therapy Study Group 2001 Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization: verteporfin in photodynamic therapy report 2 Am J Ophthalmol 131 541 560 10.1016/S0002-9394(01)00967-9 (Pubitemid 32427660)
5. Japanese Age-Related Macular Degeneration Trial (JAT) Study Group 2003 Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration Am J Ophthalmol 136 1049 1061 10.1016/S0002-9394(03)00576-2 (Pubitemid 37485771)
6. Verteporfin Roundtable Participants 2005 Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update Retina 25 119 134 10.1097/00006982-200502000-00002 (Pubitemid 40365934)
7. MN Moschos D Panayotidis MM Moschos C Bouros PG Theodossiadis GP Theodossiadis 2003 A preliminary assessment of macular function by MF-ERG in myopic eyes with CNV with complete response to photodynamic therapy Eur J Ophthalmol 13 461 467 1:STN:280:DC%2BD3szht1GrtA%3D%3D 12841569 (Pubitemid 36807131)
8. K Rüther K Breidenbach R Schwartz A Hassenstein G Richard 2003 Testing central retinal function with multifocal electroretinography before and after photodynamic therapy Ophthalmologe 100 459 464 12820013 (Pubitemid 36827684)
9. TY Lai WM Chan DS Lam 2004 Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy Am J Ophthalmol 137 826 833 10.1016/j.ajo.2003.11.079 15126146 (Pubitemid 38582034)
10. K Ishikawa M Kondo Y Ito M Kikuchi H Nishihara CH Piao T Sugita H Terasaki 2007 Correlation between focal macular electroretinograms and angiographic findings after photodynamic therapy Investig Ophthalmol Vis Sci 48 2254 2259 10.1167/iovs.06-1277 (Pubitemid 351261303)
11. A Van de Moere SS Sandhu R Kak KW Mitchell SJ Talks 2005 Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin Ophthalmology 112 1896 1903 10.1016/j.ophtha.2005.06.018 16214216 (Pubitemid 41551916)
12. RF Spaide J Sorenson L Maranan 2003 Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization Ophthalmology 110 1517 1525 10.1016/S0161-6420(03)00544-X 12917166 (Pubitemid 36962483)
13. RF Spaide J Sorenson L Maranan 2005 Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization Ophthalmology 112 301 304 10.1016/j.ophtha.2004.08.012 15691567 (Pubitemid 40202568)
14. E Rechtman RP Danis LM Pratt A Harris 2004 Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularization in age related macular degeneration Br J Ophthalmol 88 344 347 1:STN:280: DC%2BD2c7ivF2itg%3D%3D 10.1136/bjo.2003.027177 14977766 (Pubitemid 38333711)
15. WM Chan TY Lai AL Wong JP Tong DT Liu DS Lam 2006 Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularization in age related macular degeneration. A comparative study Br J Ophthalmol 90 337 341 10.1136/bjo.2005.081299 16488958 (Pubitemid 43325467)
16. I Krebs S Binder U Stolba 2006 A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy Graefes Arch Clin Exp Ophthalmol 244 863 867 1:CAS:528:DC%2BD28XntVSms7k%3D 10.1007/s00417-005-0155-8 16331486 (Pubitemid 44103335)
17. M Nicolò D Ghiglione S Lai F Nasciuti S Cicinelli G Calabria 2006 Occult with no classic choroidal neovascularization secondary to age related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin Retina 26 58 64 10.1097/00006982-200601000-00010 16395140 (Pubitemid 44391753)
18. AJ Augustin U Schmidt-Erfurth 2006 Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age related macular degeneration Ophthalmology 113 14 22 10.1016/j.ophtha.2005. 09.002 16360209 (Pubitemid 43021722)
19. JM Ruiz-Moreno J Montero S Barile M Zarbin 2006 Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome Retina 26 602 612 10.1097/00006982-200607000-00003 16829800 (Pubitemid 44620358)
20. JM Ruiz-Moreno J Montero S Barile 2006 Triamcinolone and PDT to treat exudative age-related macular degeneration and submacular hemorrhage Eur J Ophthalmol 16 426 434 1:STN:280:DC%2BD28zks1GrsQ%3D%3D 16761245 (Pubitemid 44049286)
21. AJ Augustin U Schmidt-Erfurth 2006 Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age related macular degeneration Am J Ophthalmol 141 638 645 1:CAS:528:DC%2BD28XivVaqtbY%3D 10.1016/j.ajo.2005.11.058 16564797
22. K Ishikawa H Nishihara S Ozawa CH Piao Y Ito M Kondo H Terasaki 2009 Focal macular electroretinograms after photodynamic therapy combined with posterior juxtascleral triamcinolone acetonide Retina 29 803 810 10.1097/IAE.0b013e31819c631a 19262429
23. U Schmidt-Erfurth U Schlötzer-Schrehard C Cursiefen S Michels A Beckendorf GO Naumann 2003 Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor Investig Ophthalmol Vis Sci 44 4473 4480 10.1167/iovs.02-1115 (Pubitemid 37186285)
24. R Jorge RA Costa D Calucci IU Scott 2007 Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study) Graefes Arch Clin Exp Ophthalmol 245 1273 1280 10.1007/s00417-006-0468-2 17333238 (Pubitemid 46979541)
25. BT Smith MS Dhalla GK Shah KJ Blinder EH Ryan Jr RA Mittra 2008 Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in aged-related macular degeneration Retina 28 675 681 10.1097/IAE.0b013e31816b316e 18463509 (Pubitemid 351655118)
26. G Weigert S Michels S Sacu A Varga F Prager W Geitzenauer U Schmidt-Erfurth 2008 Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomized, controlled clinical study Br J Ophthalmol 92 356 360 1:STN:280:DC%2BD1c7ktlOgtw%3D%3D 10.1136/bjo.2007.125823 18303156 (Pubitemid 351363530)
27. MS Ladewig SE Karl V Hamelmann HM Helb HP Scholl FG Holz N Eter 2008 Combined intravitreal bevacizumab and photodynamic therapy for neovascular age-related macular degeneration Graefes Arch Clin Exp Ophthalmol 246 17 25 1:CAS:528:DC%2BD2sXhtlaqsbbJ 10.1007/s00417-007-0654-x 17701197 (Pubitemid 350162680)
28. C Zuo F Wen J Li Y Liu M Li 2009 Transitions of multifocal electroretinography following combined intravitreal bevacizumab and photodynamic therapy for polypoidal choroidal vasculopathy Doc Ophthalmol 119 29 36 10.1007/s10633-009-9166-9 19184153
29. RL Avery DJ Pieramici MD Rabena AA Castellarin MA Nasir MJ Giust 2006 Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmology 113 363 372 10.1016/j.ophtha.2005.11.019 16458968
30. RF Spaide K Laud HF Fine JM Klancnik Jr CB Meyerle LA Yannuzzi J Sorenson J Slakter YL Fisher MJ Cooney 2006 Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration Retina 26 383 390 10.1097/00006982-200604000-00001 16603955 (Pubitemid 44197628)
31. RA Costa R Jorge D Calucci JA Cardillo LA Melo Jr IU Scott 2006 Intravitreal bevacizumab (Avastin) for choroidal neovascularization caused by age-related macular degeneration (IBeNA Study): results of a dose-escalation study Investig Ophthalmol Vis Sci 47 4569 4578 10.1167/iovs.06-0433 (Pubitemid 46579387)
32. D Iturralde RF Spaide CB Meyerle JM Klancnik LA Yannuzzi YL Fisher J Sorenson JS Slakter KB Freund M Cooney HF Fine 2006 Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study Retina 26 279 284 10.1097/00006982-200603000-00005 16508427 (Pubitemid 44318180)
33. S Peters P Heiduschka S Julien F Ziemssen H Fietz KU Bartz-Schmidt Tübingen Bevacizumab Study Group U Schraermeyer 2007 Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab Am J Ophthalmol 143 995 1002 1:CAS:528:DC%2BD2sXlvVakur4%3D 10.1016/j.ajo.2007.03.007 17449002 (Pubitemid 46764670)
34. Y Miyake N Shiroyama I Ota M Horiguchi 1988 Oscillatory potentials in electroretinograms of the human macular region Investig Ophthalmol Vis Sci 29 1631 1635 1:STN:280:DyaL1M%2Fjt12rsg%3D%3D
35. Y Miyake 1988 Studies of local macular ERG Acta Soc Ophthalmol Jpn 92 1419 1449 1:STN:280:DyaL1M7gt12ksg%3D%3D
36. K Ishikawa Y Ito R Mizutani M Kikuchi H Nishihara H Terasaki 2008 New computer program to analyze OCT images of fovea quantitatively before and after photodynamic therapy Jpn J Ophthalmol 52 182 189 10.1007/s10384-008-0528-8 18661268
37. Y Hatta K Ishikawa H Nishihara S Ozawa Y Ito H Terasaki 2010 Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal perfusion Retina 30 495 502 10.1097/IAE.0b013e3181bcedbe 19996828
38. R Obata A Iriyama Y Inoue H Takahashi Y Tamaki Y Yanagi 2007 Triamcinolone acetonide suppresses early proangiogenic response in RPE cells after photodynamic therapy in vitro Br J Ophthalmol 91 100 104 1:STN:280:DC%2BD28jjvFymtw%3D%3D 10.1136/bjo.2006.098004 16987905 (Pubitemid 46094019)